Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
144
datasets available to search
ShareScore release 0.9.0
Dataset results
144 results for “anti-VEGF”
Pre-Administration of Brimonidine in Intravitreal Anti-VEGF Therapy
ClinicalTrials.gov study NCT03513172. IPD Sharing: UNDECIDED. Countries: 0. Publications: 6.
Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema
ClinicalTrials.gov study NCT02979665. IPD Sharing: Not stated. Countries: 0. Publications: 5.
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
ClinicalTrials.gov study NCT02036424. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00775411. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
ClinicalTrials.gov study NCT01025232. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD
ClinicalTrials.gov study NCT04626128. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD
ClinicalTrials.gov study NCT02214628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
ClinicalTrials.gov study NCT03203447. IPD Sharing: NO. Countries: 5. Publications: 0.
Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.
ClinicalTrials.gov study NCT01449682. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
ClinicalTrials.gov study NCT04356729. IPD Sharing: YES. Countries: 1. Publications: 0.
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
ClinicalTrials.gov study NCT02387957. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
ClinicalTrials.gov study NCT04049266. IPD Sharing: NO. Countries: 7. Publications: 0.
Insights from survival analyses during 12 years of anti-VEGF therapy for neovascular age-related macular degeneration
Open the record for dataset details and reuse information.
Anti-vegf therapy in diabetic macular oedema patients over four years
Open the record for dataset details and reuse information.
Anti-VEGF treatment potentiates ICB responses through a BAFF and IL-12-dependent reprogramming of the TME
GEO Series GSE284205. Homo sapiens. 7 samples. Type: Expression profiling by high throughput sequencing.
Overcoming resistance to anti-VEGF therapy via epigenetic regulation of BARD1 [SKOV3 BARD1 siRNA-RNASeq]
GEO Series GSE247654. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Mitochondrial DNA mutations are associated with response to anti-VEGF therapy in ovarian cancer PDX models
GEO Series GSE261674. Homo sapiens. 19 samples. Type: Expression profiling by high throughput sequencing.
Overcoming resistance to anti-VEGF therapy via epigenetic regulation of BARD1 [BeadChip expression]
GEO Series GSE249415. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Expression profiling of ccRCC samples treated with anti-VEGF therapies reveals distinct markers
GEO Series GSE25698. Homo sapiens. 32 samples. Type: Expression profiling by array.
Overcoming resistance to anti-VEGF therapy via epigenetic regulation of BARD1 [methylation]
GEO Series GSE247655. Homo sapiens. 8 samples. Type: Methylation profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.